{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T14:21:25Z","timestamp":1782138085949,"version":"3.54.5"},"reference-count":0,"publisher":"Physicians Postgraduate Press, Inc","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Psychiatry"],"published-print":{"date-parts":[[1998,4,15]]},"DOI":"10.4088\/jcp.v59n0404","type":"journal-article","created":{"date-parts":[[2010,11,12]],"date-time":"2010-11-12T20:03:38Z","timestamp":1289592218000},"page":"165-171","source":"Crossref","is-referenced-by-count":143,"title":["Efficacy and Safety of Fluvoxamine in Body Dysmorphic Disorder"],"prefix":"10.4088","volume":"59","author":[{"given":"Katharine A.","family":"Phillips","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan M.","family":"Dwight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"McElroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2558","container-title":["The Journal of Clinical Psychiatry"],"original-title":[],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T12:27:16Z","timestamp":1698755236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.psychiatrist.com\/jcp\/efficacy-safety-fluvoxamine-body-dysmorphic-disorder"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,4,15]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1998,4,15]]}},"URL":"https:\/\/doi.org\/10.4088\/jcp.v59n0404","relation":{},"ISSN":["0160-6689"],"issn-type":[{"value":"0160-6689","type":"print"}],"subject":[],"published":{"date-parts":[[1998,4,15]]}}}